Kathleen Ford
Chief Operating Officer bei KURA ONCOLOGY, INC.
Vermögen: 460 771 $ am 31.03.2024
Profil
Kathleen Ford is currently the Chief Operating Officer at Kura Oncology, Inc. She previously worked as the Director of Clinical Operations at Alkermes, Inc. and Alkermes Plc from 1993 to 2002.
From 2012 to 2017, she served as the Senior VP and Head of Global Clinical Operations at Merck Serono GmbH.
Additionally, she held the position of Vice President of Clinical Operations at Millennium Pharmaceuticals, Inc. from 2002 to 2009.
Ms. Ford obtained her undergraduate degree from Fitchburg State College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KURA ONCOLOGY, INC.
0,03% | 29.01.2024 | 21 602 ( 0,03% ) | 460 771 $ | 31.03.2024 |
Aktive Positionen von Kathleen Ford
| Unternehmen | Position | Beginn |
|---|---|---|
| KURA ONCOLOGY, INC. | Chief Operating Officer | 09.08.2019 |
Ehemalige bekannte Positionen von Kathleen Ford
| Unternehmen | Position | Ende |
|---|---|---|
Merck Serono GmbH
 Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Chief Tech/Sci/R&D Officer | 01.01.2017 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.01.2009 |
| ALKERMES PLC | Chief Tech/Sci/R&D Officer | 01.01.2002 |
Ausbildung von Kathleen Ford
| Fitchburg State College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KURA ONCOLOGY, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Health Technology |
